A meta-analysis associated with gastric cancer indicated that ADAM17 might be a tumor marker for poor prognosis in gastric cancer, and high expression of ADAM17 is associated with lymph node metastasis and clinical staging of lymph node metastasis in gastric cancer (15). This evidence concerns the gene ADAM17 and neoplasm.